FIELD: medicine, pharmaceutics. SUBSTANCE: the present innovation deals with treating both alcoholic and medicinal addiction including therapeutically efficient amount of (i) opioid antagonist and (ii) NMDA modulator of receptor complex. Moreover, pharmaceutical kit is suggested including (i) opioid antagonist and (ii) NMDA modulator of receptor complex. EFFECT: higher efficiency of therapy. 10 cl, 1 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF MAVOGLURANT TO REDUCE ALCOHOL USE OR TO PREVENT RECURRENT ALCOHOL USE | 2018 |
|
RU2806869C2 |
| AGENT FOR PREVENTION AND TREATMENT OF ALCOHOLISM AND METHOD OF ITS APPLICATION | 2007 |
|
RU2343908C1 |
| COMPOSITIONS AND METHODS OF PREVENTING AND TREATING ADDICTIONS | 2008 |
|
RU2492858C2 |
| USE OF OPIOID RECEPTOR ANTAGONIST WITH K-ACTIVITY AND VORTIOXETINE FOR TREATMENT OF DEPRESSIVE DISORDER WITH MELANCHOLIC FEATURES | 2014 |
|
RU2679661C1 |
| MEANS FOR REDUCING ALCOHOL MOTIVATION IN ALCOHOL DEPENDENCE | 2014 |
|
RU2582966C2 |
| MEDICIATION FOR PREVENTION AND TREATMENT OF ALCOHOL DEPENDENCE AND DEPENDENCE FROM MEDICATIONS | 2007 |
|
RU2419433C2 |
| AGENT FOR MANAGING ALCOHOL ABSTINENCE SYNDROME | 2012 |
|
RU2521226C2 |
| AGENT TO REDUCE ALCOHOL ADDICTION, PHARMACEUTICAL COMPOSITION, METHOD FOR MAKING THEREOF, MEDICINAL AGENT AND METHOD OF TREATING | 2009 |
|
RU2404976C1 |
| COMPOSITIONS, DEVICES AND METHODS FOR THE TREATMENT OF ALCOHOL DEPENDENCE | 2017 |
|
RU2767062C2 |
| AGENT FOR PREVENTION AND TREATMENT OF ALCOHOLISM AND OPIOMANIA | 2008 |
|
RU2393864C1 |
